• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Watching Shares Of GSK; UBS Note Says ACIP Working Group Recommends Universal RSV Vaccine for Age 75+ From SCD; No Endorsement for Ages 50-59 Due to Limited Data; 60-74 Recommendation Only for "At Risk"

    6/26/24 1:38:23 PM ET
    $GSK
    $UBS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Banks
    Finance
    Get the next $GSK alert in real time by email
    Watching Shares Of GSK; UBS Note Says ACIP Working Group Recommends Universal RSV Vaccine for Age 75+ From SCD; No Endorsement for Ages 50-59 Due to Limited Data; 60-74 Recommendation Only for "At Risk"
    Get the next $GSK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GSK
    $UBS

    CompanyDatePrice TargetRatingAnalyst
    UBS Group AG Registered
    $UBS
    2/6/2026Buy → Neutral
    Goldman
    GSK plc
    $GSK
    1/27/2026Neutral
    Citigroup
    GSK plc
    $GSK
    1/6/2026Equal Weight → Underweight
    Barclays
    UBS Group AG Registered
    $UBS
    12/16/2025$60.30Neutral → Buy
    BofA Securities
    GSK plc
    $GSK
    11/25/2025Underperform → Neutral
    BofA Securities
    UBS Group AG Registered
    $UBS
    7/22/2025Underperform → Neutral
    BofA Securities
    UBS Group AG Registered
    $UBS
    6/18/2025Equal-Weight → Underweight
    Morgan Stanley
    GSK plc
    $GSK
    6/3/2025Buy → Hold
    Berenberg
    More analyst ratings

    $GSK
    $UBS
    SEC Filings

    View All

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/19/26 10:01:19 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/19/26 7:17:12 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by GSK plc

    6-K - GSK plc (0001131399) (Filer)

    3/18/26 12:50:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GSK
    $UBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $GSK
    $UBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $GSK
    $UBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    UBS AG downgraded by Goldman

    Goldman downgraded UBS AG from Buy to Neutral

    2/6/26 8:10:36 AM ET
    $UBS
    Major Banks
    Finance

    Citigroup initiated coverage on GlaxoSmithKline

    Citigroup initiated coverage of GlaxoSmithKline with a rating of Neutral

    1/27/26 8:46:26 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GlaxoSmithKline downgraded by Barclays

    Barclays downgraded GlaxoSmithKline from Equal Weight to Underweight

    1/6/26 11:51:57 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

    In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* GSK plc (LSE/NYSE:GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18 to 49 years at increased risk for lower respiratory tract disease (LRTD) caused by RSV. AREXVY was previously approved in the US for the prevention of RSV-related LRTD in adults aged 60 and older, and adults aged 50–59 at increased risk for LRTD caused by RSV. This vaccine is not for use in pregnant individuals. Sanjay Gurunathan, GSK Head of Vaccines and Infectious Diseases Re

    3/13/26 11:44:00 AM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production

    Executive Advisory Board now includes more than 30 senior leaders from Fortune 500 and global enterprisesNEW YORK, March 11, 2026 /PRNewswire/ -- Myriad Venture Partners ("Myriad"), an early-stage venture capital firm focused on defining the future of business solutions in enterprise AI, enterprise B2B software, and industrial transformation, today announced the expansion of its Executive Advisory Board, bringing the Board to more than 30 C-suite leaders from Fortune 500 and global enterprises. New executives joining the Board include leaders from GSK, Mastercard, Harley-Davidson, Meta, Oracle, and other global companies, further strengthening Myriad's hands-on model and deepening its ties t

    3/11/26 6:00:00 AM ET
    $AON
    $GSK
    $HOG
    Specialty Insurers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UBS declares coupon payments on 8 ETRACS Exchange Traded Notes

    HDLB: linked to the Solactive US High Dividend Low Volatility Index SMHB: linked to the Solactive US Small Cap High Dividend Index PFFL: linked to the Solactive Preferred Stock ETF Index CEFD: linked to the S-Network Composite Closed-End Fund Index MVRL: linked to the MVIS US Mortgage REITs Index GLDI: linked to the Nasdaq Gold FLOWS™ 103 Index SLVO: linked to the Nasdaq Silver FLOWS™ 106 Index USOI: linked to the Nasdaq WTI Crude Oil FLOWS™ 106 Index UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the "ETNs"). NYSE Ticker   E

    3/4/26 4:30:00 PM ET
    $GLDI
    $SLVO
    $UBS
    Investment Bankers/Brokers/Service
    Finance
    Blank Checks
    Major Banks

    Large owner Ubs Group Ag disposed of $975,000 worth of Auction Preferred Stock (39 units at $25,000.00) (SEC Form 4)

    4 - UBS Group AG (0001610520) (Reporting)

    6/28/24 8:49:31 AM ET
    $UBS
    Major Banks
    Finance

    Large owner Ubs Group Ag disposed of $450,000 worth of Auction Preferred Stock (18 units at $25,000.00) (SEC Form 4)

    4 - UBS Group AG (0001610520) (Reporting)

    6/28/24 8:37:16 AM ET
    $UBS
    Major Banks
    Finance

    Large owner Ubs Group Ag disposed of $150,000 worth of Auction Preferred Stock (6 units at $25,000.00) (SEC Form 4)

    4 - UBS Group AG (0001610520) (Reporting)

    6/27/24 9:48:32 AM ET
    $UBS
    Major Banks
    Finance

    $GSK
    $UBS
    Leadership Updates

    Live Leadership Updates

    View All

    UBS Appoints Justin Frame to Lead Tucson, Arizona Office

    UBS Global Wealth Management today announced that Justin Frame, Managing Director and Market Executive for the Pacific Desert Market, has been appointed additional responsibility of the UBS Tucson, Arizona, office. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251203039576/en/Justin Frame, Managing Director and Market Executive for the UBS Pacific Desert Market, has been appointed additional responsibility of the UBS Tucson, Arizona, office. Since June 2020, Justin has led the UBS Pacific Desert Market, comprising of 15 offices across Southern California, San Diego, the Inland Empire, Hawaii, and Arizona. He continues to oversee

    12/3/25 12:28:00 PM ET
    $UBS
    Major Banks
    Finance

    Daniel Holzer joins UBS as Financial Advisor in Westport, CT

    UBS Global Wealth Management US today announced that Daniel Holzer has joined the firm as a Financial Advisor. Dan joins the UBS Westport, Connecticut office, which is managed by Market Director Jim Miller and is part of the Greater New York Market, led by Market Executive Mara Glassel. "On behalf of UBS, we're excited to welcome Dan to the firm," said Jim Miller, Market Director at UBS Wealth Management. "His industry experience and dedication to his clients will be a great addition to our business, and we look forward to having him help us continue to expand our client offering in this key market." A dedicated financial advisor for his entire 29-year career, Dan joins UBS after a long

    11/10/25 2:07:00 PM ET
    $UBS
    Major Banks
    Finance

    UBS Hires Ryan Rozniakowski as Senior Market Director for Northern New Jersey

    UBS is pleased to announce the appointment of Ryan Rozniakowski as Senior Market Director for Northern New Jersey within the Greater New York Metro Market. Ryan leads UBS's Paramus office, the firm's largest branch in New Jersey, where he is responsible for overseeing strategic growth, driving profitability, and leading a team of more than 130 employees. His appointment underscores the importance of Paramus as a critical business within the Greater New York Metro Market and emphasizes UBS's commitment to high-impact leadership. Ryan's local leadership team includes Christopher Simone, Associate Market Executive. In his career at UBS, Ryan has earned a reputation for leading high-perform

    8/18/25 9:03:00 AM ET
    $UBS
    Major Banks
    Finance

    $GSK
    $UBS
    Financials

    Live finance-specific insights

    View All

    UBS declares coupon payments on 8 ETRACS Exchange Traded Notes

    HDLB: linked to the Solactive US High Dividend Low Volatility Index SMHB: linked to the Solactive US Small Cap High Dividend Index PFFL: linked to the Solactive Preferred Stock ETF Index CEFD: linked to the S-Network Composite Closed-End Fund Index MVRL: linked to the MVIS US Mortgage REITs Index GLDI: linked to the Nasdaq Gold FLOWS™ 103 Index SLVO: linked to the Nasdaq Silver FLOWS™ 106 Index USOI: linked to the Nasdaq WTI Crude Oil FLOWS™ 106 Index UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the "ETNs"). NYSE Ticker   E

    3/4/26 4:30:00 PM ET
    $GLDI
    $SLVO
    $UBS
    Investment Bankers/Brokers/Service
    Finance
    Blank Checks
    Major Banks

    UBS Declares Coupon Payments on 8 ETRACS Exchange Traded Notes

    HDLB: linked to the Solactive US High Dividend Low Volatility Index SMHB: linked to the Solactive US Small Cap High Dividend Index PFFL: linked to the Solactive Preferred Stock ETF Index CEFD: linked to the S-Network Composite Closed-End Fund Index MVRL: linked to the MVIS US Mortgage REITs Index GLDI: linked to the Nasdaq Gold FLOWS™ 103 Index SLVO: linked to the Nasdaq Silver FLOWS™ 106 Index USOI: linked to the Nasdaq WTI Crude Oil FLOWS™ 106 Index UBS Investment Bank today announced coupon payments for 5 ETRACS Exchange Traded Notes traded on the NYSE Arca and expected coupon payments for 3 ETRACS Exchange Traded Notes traded on NASDAQ (together, the "ETNs"). NYSE Ti

    2/5/26 4:30:00 PM ET
    $GLDI
    $SLVO
    $UBS
    Investment Bankers/Brokers/Service
    Finance
    Blank Checks
    Major Banks

    UBS Declares Coupon Payments on 12 ETRACS Exchange Traded Notes

    MLPB: linked to the Alerian MLP Infrastructure Index MLPR: linked to the Alerian MLP Index BDCZ: linked to the MarketVector US Business Development Companies Liquid Index BDCX: linked to the MarketVector US Business Development Companies Liquid Index HDLB: linked to the Solactive US High Dividend Low Volatility Index SMHB: linked to the Solactive US Small Cap High Dividend Index PFFL: linked to the Solactive Preferred Stock ETF Index CEFD: linked to the S-Network Composite Closed-End Fund Index MVRL: linked to the MVIS US Mortgage REITs Index GLDI: linked to the Nasdaq Gold FLOWS™ 103 Index SLVO: linked to the Nasdaq Silver FLOWS™ 106 Index USOI: linked to the Nasdaq WTI Crude Oil FLOWS™ 10

    1/6/26 4:30:00 PM ET
    $GLDI
    $SLVO
    $UBS
    Investment Bankers/Brokers/Service
    Finance
    Blank Checks
    Major Banks

    $GSK
    $UBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GSK plc

    SC 13G/A - GSK plc (0001131399) (Subject)

    11/12/24 4:32:59 PM ET
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by UBS Group AG Registered

    SC 13G - UBS Group AG (0001610520) (Subject)

    11/8/24 12:14:54 PM ET
    $UBS
    Major Banks
    Finance

    Amendment: SEC Form SC 13G/A filed by UBS Group AG Registered

    SC 13G/A - UBS Group AG (0001610520) (Filed by)

    6/28/24 9:22:44 AM ET
    $UBS
    Major Banks
    Finance